Back to the search results

Stauferklinikum Schwäbisch-Gmünd

Wetzgauer Str. 85
73557 Mutlangen

Phone: 07171-7010
Fax: 07171-701-1009
Mail: ed.blatso-nekinilk@ofni

  • Number of beds: 401
  • Number of specialist departments: 18
  • Number of inpatient cases: 16.760
  • Number of partial inpatient cases: 1
  • Number of outpatient cases: 38.333
  • Hospital owners: Ostalbkreis vertreten durch Herrn Landrat Dr. Joachim Bläse Stuttgarter Straße 41 73430 Aalen
  • Type of provider: öffentlich
  • Academic teaching hospital
      • Universität Ulm
      • Medizinische Falkultät
      • Albert-Einstein-Allee 7
      • 89081 Ulm
External comparative quality assurance
Further information
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Bezeichnung
Teilnahme externe Qualitätssicherung yes
Quantity performed 86
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 18
Quantity forecast year: 21
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 86
Quantity forecast year: 88
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
No. Explanation
CQ05 Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1
CQ07 Measures for quality assurance in the care of pre-term and full-term neonates – perinatal focus
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: yes
Number Group
93 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
55 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
55 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission

Aufnahmedokumentation Elektive Aufnahme stat, Chemo

01.07.2020

Organigramm mit Aufgaben- / Tätigkeitsbeschreibung

01.07.2023

  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Medical E-shop elektronisches Bestellsystem für Arzneimittel; Anforderungs-/Herstellungssoftware Cato: Therapieprotokolle für Zytostasen Apothekern evidenzbasiert angelegt
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Training in other healing professions
Comment

Comment

Comment

Comment

Praktische Ausbildungseinsätze in der Klinik

Ehrenamtskoordinatorin Brigitte Abele

Patientenfürsprecherin und Krankenhaushilfsdienst

Wetzgauer Str. 85
73557 Mutlangen

Phone: 07171 -701-2080
Mail: ed.blatsO-nekinilk@eleba.ettigirB

Zentrales Qualitätsmanagement Martell Malessa

Beschwerdemanagement

Wetzgauer Str. 85
73557 Mutlangen

Phone: 07171 -701-3535
Mail: ed.blatsO-nekinilk@asselam.lletram

Leitung Martell Malessa

Qualitätsmanagement, Qualitätssicherung, Benchmarking, Dokumentenlenkung, Fehler-/ Beschwerde-/Risikomanagement

Wetzgauer Str. 85
73557 Mutlangen

Phone: 07171 -701-3535
Mail: ed.blatso-nekinilk@asselam.lletram

Prof. Dr. Holger Hebart

Vorsitzender

Wetzgauer Str. 85
73557 Mutlangen

Phone: 07171 -701-1301
Mail: ed.blatso-nekinilk@trabeh.regloh

Dr. Jens Holtappels

Leitender Fachapotheker

Wetzgauer Str. 85
73557 Mutlangen

Phone: 07171 -701-3201
Mail: ed.blatso-nekinilk@sleppatloh.snej

Herr Martell Malessa

Qualitäts- & Beschwerdemanagement

Wetzgauer Str. 85
73557 Mutlangen

Phone: 07171 -701-3535
Mail: ed.blatso-nekinilk@asselam.lletram

Wetzgauer Str. 85
73557 Mutlangen

Phone: 07171-7010
Fax: 07171-701-1009
Mail: ed.blatso-nekinilk@ofni

Frau Patricia Klein

Pflegerische Standortleiterin

Wetzgauer Str. 85
73557 Mutlangen

Phone: 07171 -701-2002
Mail: ed.blatso-nekinilk@nielk.aicirtap

Christopher Franken

Standortleitung

Wetzgauer Str. 85
73557 Mutlangen

Phone: 07171 -701-1101
Mail: ed.blatso-nekinilk@neknarf.rehpotsirhC

Prof. Dr. Holger Hebart

Ärztlicher Direktor

Wetzgauer Str. 85
73557 Mutlangen

Phone: 07171 -701-1302
Mail: ed.blatso-nekinilk@trabeh.regloH

IK: 260811579

Location number: 771470000

Old location number: 771470000

Onkologisches Zentrum

Certified until: 07.2025

Gynäkologisches Krebszentrum

Certified until: 07.2025

Brustzentrum

Certified until: 07.2025

Darmzentrum

Certified until: 07.2025

Zentrum für Hämatologische Neoplasien

Certified until: 07.2025

EndoProthetikZentrum der Maximalversorgung

Certified until: 07.2025

Regionales Traumazentrum

Certified until: 03.2026

Lokale Schlaganfallstation

Certified until: 11.2026

Wirbelsäulenspezialzentrum

Certified until: 11.2027